LPL Financial
ANTX icon

LPL Financial’s AN2 Therapeutics ANTX Stock Holding History

LPL Financial’s Portfolio ANTX Stock Details ANTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$59.8K Buy
+12,350
New +$53.1K ﹤0.01% 6004

Other funds holding ANTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial's ANTX Position: Q2 2026 in Review

LPL Financial opened a new position in AN2 Therapeutics (ANTX) in Q2 2026: 12,350 shares worth $59.8K. The stake represents ﹤0.01% of the portfolio and ranks #6004 among its holdings.

27 funds tracked by Wall St. Rank hold ANTX as of Q2 2026.

  • LPL Financial held 12,350 shares of AN2 Therapeutics worth $59.8K as of Q2 2026.
  • AN2 Therapeutics was a new LPL Financial position in Q2 2026.
  • AN2 Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #6004 holding.
  • 27 funds tracked by Wall St. Rank held AN2 Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.